Amicus Therapeutics Inc

NASDAQ:FOLD   3:59:50 PM EDT
10.81
+0.01 (+0.09%)
Other Pre-Announcement

Amicus Therapeutics Q3 Revenue Rose 18 Percent To $79.5 Mln

Published: 11/09/2021 12:47 GMT
Amicus Therapeutics Inc (FOLD) - Q3 Loss per Share $0.19.
Sees FY Revenue $300 Million to $315 Million.
Q3 Revenue Rose 18 Percent to $79.5 Million.
Amicus - Believes Current Cash Position, Expected Future Revenue Are Enough to Fund Co's Operations, Ongoing Research Programs Through to Self-sustainability.